Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Refined By:
Department:  DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Subject:  Parkinson's disease
Policy:  Open

Results 1-11 of 11 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
12011A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's diseaseKrüger R.; Sharma M.; Riess O.; Gasser T.; Van Broeckhoven C.; Theuns J.; Aasly J.; Annesi G.; Bentivoglio A.R.; Brice A.; Djarmati A.; Elbaz A.; Farrer M.; Ferrarese C.; Gibson J.M.; Hadjigeorgiou G.M.; Hattori N.; Ioannidis J.P.A.; Jasinska-Myga B.; Klein C.; Lambert J.-C.; Lesage S.; Lin J.-J.; Lynch T.; Mellick G.D.; de Nigris F.; Opala G.; Prigione A.; Quattrone A.; Ross O.A.; Satake W.; Silburn P.A.; Tan E.K. ; Toda T.; Tomiyama H.; Wirdefeldt K.; Wszolek Z.; Xiromerisiou G.; Maraganore D.M.
22017Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyWang L.; Heckman M.G.; Aasly J.O.; Annesi G.; Bozi M.; Chung S.J.; Clarke C.; Crosiers D.; Eckstein G.; Garraux G.; Hadjigeorgiou G.M.; Hattori N.; Jeon B.; Kim Y.J.; Kubo M.; Lesage S.; Lin J.J.; Lynch T.; Lichtner P.; Mellick G.D.; Mok V.; Morrison K.E.; Quattrone A.; Satake W.; Silburn P.A.; Stefanis L.; Stockton J.D.; Tan E.K. ; Toda T.; Brice A.; Van Broeckhoven C.; Uitti R.J.; Wirdefeldt K.; Wszolek Z.; Xiromerisiou G.; Maraganore D.M.; Gasser T.; Krüger R.; Farrer M.J.; Ross O.A.; Sharma M.
317-Jan-2020Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's DiseaseDeng, X; Xiao, B; Li, HH; Ng, E; Lo, YL ; Tan, EK ; Prakash, KM 
42017Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's DiseaseQiu L. ; Liao M.-C.; Chen A.K.; Wei S.; Xie S. ; Reuveny S.; Zhou Z.D. ; Hunziker W. ; Tan E.K. ; Oh S.K.W. ; Zeng L. 
52015Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese populationYu W.-J.; Cheng L.; Li N.-N.; Wang L.; Tan E.-K. ; Peng R.
62017Mild cognitive impairment in Parkinson's disease: A distinct clinical entity?Wen M.-C. ; Chan L.L. ; Tan L.C.S. ; Tan E.K. 
71-May-2022Parkinson's Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1Tan, Jolene Su Yi; Lee, Bernett; Lim, Jackwee; Ma, Dong Rui; Goh, Jia Xin; Goh, Suh Yee ; Gulam, Muhammad Yaaseen ; Koh, Ser Mei; Lee, Weiling Wendy; Feng, Lei ; Wang, Qing; Chao, Yinxia ; Rotzschke, Olaf; Tan, Eng King 
82016Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of ?-synuclein via SIRT1-deacetylated LC3Guo Y.-J.; Dong S.-Y.; Cui X.-X.; Feng Y.; Liu T.; Yin M.; Kuo S.-H.; Tan E.-K. ; Zhao W.-J.; Wu Y.-C.
91-Nov-2019Role of MicroRNAs in Parkinson's DiseaseGoh, Suh Yee ; Chao, Yin Xia; Dheen, Shaikali Thameem ; Tan, Eng-King ; Tay, Samuel Sam-Wah 
1016-Aug-2019The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD)Zhou, Zhidong ; Xie, Shao Ping; Saw, Wuan Ting; Ho, Patrick Ghim Hoe; Wang, Hong Yan; Zhou, Lei ; Zhao, Yi; Tan, Eng King 
1111-May-2021Trans-Ethnic Fine-Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's DiseaseNaito, Tatsuhiko; Satake, Wataru; Ogawa, Kotaro; Suzuki, Ken; Hirata, Jun; Foo, Jia Nee; Tan, Eng-King ; Toda, Tatsushi; Okada, Yukinori